{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:44:08Z","timestamp":1785786248553,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rcsop.2024.100507","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T18:11:02Z","timestamp":1726078262000},"page":"100507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand"],"prefix":"10.1016","volume":"16","author":[{"given":"Chayanat","family":"Pongsathabordee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyachat","family":"Saringkarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjana","family":"Ratanapornsompong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratiya","family":"Rungruang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranporn","family":"Srithonrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimlada","family":"Tangkaotong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salintip","family":"Sena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taniya","family":"Paiboonvong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5853\/jos.2014.16.1.1","article-title":"Stroke epidemiology in Thailand","volume":"16","author":"Suwanwela","year":"2014","journal-title":"J Stroke"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12883-021-02353-y","article-title":"Stroke risk factors, subtypes and outcome in elderly Thai patients","volume":"21","author":"Samuthpongtorn","year":"2021","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0015","first-page":"169","article-title":"Prevalence of acute Cardioembolic stroke in stroke unit in Rajavithi hospital","volume":"38","author":"Prachyaarporn","year":"2022","journal-title":"Thai Journal of Neurology"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100507_bb0020","first-page":"727","article-title":"Prevalence of cardiac arrhythmias in Thai community","volume":"82","author":"Kiatchoosakun","year":"1999","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100507_bb0025","first-page":"270","article-title":"Prevalence of atrial fibrillation in Thai elderly","volume":"13","author":"Phrommintikul","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.rcsop.2024.100507_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12872-016-0232-4","article-title":"Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study","volume":"16","author":"Krittayaphong","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"83","author":"Writing Committee Members","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100507_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rcsop.2024.100507_bb0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fmed.2020.00350","article-title":"Anticoagulation therapy for non-valvular atrial fibrillation: a Mini-review","volume":"7","author":"Wu","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100507_bb0050","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.rcsop.2024.100507_bb0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rcsop.2024.100507_bb0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2023.03.007","article-title":"Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: a narrative review","volume":"231","author":"van der Horst","year":"2023","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100507_bb0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.hlc.2019.02.187","article-title":"Cost-effectiveness analysis of non-vitamin K antagonist Oral anticoagulants versus warfarin in Thai patients with non-Valvular atrial fibrillation","volume":"29","author":"Dilokthornsakul","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.rcsop.2024.100507_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221130058","article-title":"Effectiveness and safety of direct Oral anticoagulants in Thai patients with atrial fibrillation: a real-world retrospective cohort study","volume":"28","author":"Srikajornlarp","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100507_bb0075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/cpt.2090","article-title":"Real-world comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in a developing country","volume":"109","author":"Mitsuntisuk","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2024.100507_bb0080","article-title":"Real-world prevalence of direct Oral anticoagulant off-label doses in atrial fibrillation: an epidemiological Meta-analysis","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100507_bb0085","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/heartjnl-2022-321114","article-title":"Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"109","author":"Caso","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.rcsop.2024.100507_bb0090","article-title":"Effectiveness and safety of under or over- dosing of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 148909 patients from 10 real-world studies","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100507_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bcp.15017","article-title":"Determinants for under- and overdosing of direct oral anticoagulants and physicians\u2019 implementation of clinical pharmacists\u2019 recommendations","volume":"88","author":"Moudallel","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100507_bb0100","series-title":"PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study [published correction appears in Cardiovasc Drugs Ther]","first-page":"601","volume":"38(3)","author":"Kocaba\u015f","year":"2024"},{"key":"10.1016\/j.rcsop.2024.100507_bb0105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/bcp.14535","article-title":"Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand","volume":"87","author":"Wattanaruengchai","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0110","doi-asserted-by":"crossref","DOI":"10.62691\/vmj.2024.266163","article-title":"Appropriate use of anticoagulants among Nonvalvular atrial fibrillation patients at a University Hospital in Thailand","volume":"68","author":"Sureeyathanaphat","year":"2024","journal-title":"Vajira Med J"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100507_bb0115","first-page":"114","article-title":"Drug use review and dose appropriateness of new Oral anticoagulants in outpatients at Srinagarind hospital","volume":"33","author":"Meearsa","year":"2018","journal-title":"SRIMEDJ"},{"issue":"847\u2013855","key":"10.1016\/j.rcsop.2024.100507_bb0120","article-title":"Effectiveness and safety of off-label dose-reduced direct Oral anticoagulants in atrial fibrillation","volume":"132","author":"Arbel","year":"2019","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100507_bb0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/europace\/eux316","article-title":"Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA registry","volume":"20","author":"Ruiz Ortiz","year":"2018","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100507_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014108","article-title":"Rates of potentially inappropriate dosing of direct-acting Oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF study","volume":"9","author":"Sanghai","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"10.1016\/j.rcsop.2024.100507_bb0135","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","article-title":"Off-label dosing of non-vitamin K antagonist Oral anticoagulants and adverse outcomes: the ORBIT-AF II registry","volume":"68","author":"Steinberg","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100507_bb0140","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4022\/jafib.1478","article-title":"Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation","volume":"9","author":"Lavoie","year":"2016","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.rcsop.2024.100507_bb0145","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.rcsop.2024.100507_bb0150","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in east Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.rcsop.2024.100507_bb0155","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1253\/circj.CJ-15-1082","article-title":"Edoxaban vs. warfarin in east Asian patients with atrial fibrillation- an ENGAGE AF-TIMI 48 subanalysis","volume":"80","author":"Yamashita","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.rcsop.2024.100507_bb0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0165","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41598-024-55500-z","article-title":"Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: a nationwide, propensity score study","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100507_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1310\/hpj5203-207","article-title":"Assessment of direct Oral anticoagulant prescribing and monitoring pre- and post-implementation of a pharmacy protocol at a community teaching hospital","volume":"52","author":"Miele","year":"2017","journal-title":"Hosp Pharm"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100507_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Policy Res"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T21:16:06Z","timestamp":1745010966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276624001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S2667276624001045"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100507","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100507"}}